India to United States: Docusate Export Trade Route
India has recorded 204 verified shipments of Docusate exported to United States, representing a combined trade value of $6.2M USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $30.4K USD. The leading Indian exporter is TRUECARE BIOMEDIX, which accounts for 69% of total export value with 111 shipments worth $4.3M USD. On the buying side, PL DEVELOPMENTS is the largest importer in United States with $4.0M USD in purchases. The top 3 suppliers — TRUECARE BIOMEDIX, TRUE CARE BIOMEDIX, ELYSIUM PHARMACEUTICALS LTD — together control 92% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Docusate corridor is one of India's established pharmaceutical export routes, with 204 shipments documented worth a combined $6.2M USD. The route is dominated by TRUECARE BIOMEDIX, which alone accounts for roughly 69% of all export value, reflecting the consolidated nature of India's docusate manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $30.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with docusate's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 15.6%, placing it at rank #18 among India's top docusate export destinations globally.
On the import side, key buyers of Indian docusate in United States include PL DEVELOPMENTS, GERICARE PHARMACEUTICALS CORP., GERICARE PHARMACEUTICALS CORP and 36 others. PL DEVELOPMENTS is the single largest importer with 85 shipments valued at $4.0M USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ2
- Primary modeSea freight
- Top portMUNDRA SEA
Market Position
- Global rank#18
- Annual growth+15.6%
- Demand growth+13.6%
- Regulatory ease85/100
Top 10 Indian Docusate Exporters to United States
Showing top 10 of 11 Indian suppliers exporting Docusate to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TRUECARE BIOMEDIX Avg $38.3K per shipment | 111 | $4.3M | 68.6% |
| 2 | TRUE CARE BIOMEDIX Avg $64.1K per shipment | 19 | $1.2M | 19.6% |
| 3 | ELYSIUM PHARMACEUTICALS LTD Avg $23.5K per shipment | 9 | $211.4K | 3.4% |
| 4 | MEDICINEXT PHARMA LLP Avg $6.7K per shipment | 21 | $140.4K | 2.3% |
| 5 | ALDER BIOCHEM PRIVATE LIMITED Avg $13.7K per shipment | 8 | $109.8K | 1.8% |
| 6 | MARKSANS PHARMA LIMITED Avg $17.1K per shipment | 6 | $102.5K | 1.7% |
| 7 | MEDGEL PRIVATE LIMITED Avg $59.3K per shipment | 1 | $59.3K | 1.0% |
| 8 | SOFTGEL HEALTHCARE PRIVATE LIMITED Avg $12.2K per shipment | 4 | $48.9K | 0.8% |
| 9 | ELYSIUM PHARMACEUTICALS LIMITED Avg $14.7K per shipment | 3 | $44.1K | 0.7% |
| 10 | CUBIT LIFESCIENCES LLP Avg $12.6K per shipment | 1 | $12.6K | 0.2% |
This table shows the top 10 of 11 Indian companies exporting docusate to United States, ranked by total trade value. The listed exporters are: TRUECARE BIOMEDIX, TRUE CARE BIOMEDIX, ELYSIUM PHARMACEUTICALS LTD, MEDICINEXT PHARMA LLP, ALDER BIOCHEM PRIVATE LIMITED, MARKSANS PHARMA LIMITED, MEDGEL PRIVATE LIMITED, SOFTGEL HEALTHCARE PRIVATE LIMITED, ELYSIUM PHARMACEUTICALS LIMITED, CUBIT LIFESCIENCES LLP. TRUECARE BIOMEDIX is the dominant supplier with 111 shipments worth $4.3M USD, giving it a 69% market share. The top 3 suppliers together account for 92% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to United States Docusate export route.
Top 10 Docusate Importers in United States
Showing top 10 of 39 known buyers in United States receiving Docusate shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian docusate in United States include PL DEVELOPMENTS, GERICARE PHARMACEUTICALS CORP., GERICARE PHARMACEUTICALS CORP, GERICARE PHARMACEUTICALS, STRIVE PHARMACEUTICALS, among 39 total buyers. The largest importer is PL DEVELOPMENTS, accounting for $4.0M USD across 85 shipments — representing 65% of all docusate imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PL DEVELOPMENTS | 85 | $4.0M | 65.0% |
| 2 | GERICARE PHARMACEUTICALS CORP. | 21 | $575.7K | 9.3% |
| 3 | GERICARE PHARMACEUTICALS CORP | 6 | $348.7K | 5.6% |
| 4 | GERICARE PHARMACEUTICALS | 6 | $145.8K | 2.4% |
| 5 | STRIVE PHARMACEUTICALS | 8 | $141.3K | 2.3% |
| 6 | PRIVATE LIMITED DEVELOPMENTS | 2 | $140.8K | 2.3% |
| 7 | HHH PHARMACEUTIGALS | 6 | $124.9K | 2.0% |
| 8 | TO THE ORDER OF | 18 | $106.3K | 1.7% |
| 9 | SHREE HARI INTERNATIONAL LLC | 4 | $89.5K | 1.4% |
| 10 | SHIELD PHARMACEUTICALS CORP. | 7 | $88.8K | 1.4% |
Showing top 10 of 39 Docusate importers in United States on this route.
Top 10 Docusate Formulations Imported by United States
Showing top 10 of 104 product formulations shipped on the India to United States Docusate route, ranked by trade value
United States imports a wide range of docusate formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Sennosides & Docusate Sodium Tablet 8.6m — accounts for $513.6K USD across 13 shipments. There are 104 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Sennosides & Docusate Sodium Tablet 8.6m | 13 | $513.6K | 8.3% |
| 2 | Sennosides & Docusate Sodium Tablet 8.6m | 5 | $442.8K | 7.1% |
| 3 | Sennosides & Docusate Sodium Tablet 8.6mg/50mg (Red) | 5 | $348.9K | 5.6% |
| 4 | Sennosides & Docusate Sodium Tablet 8.6mg/50mg Red OTHER DETAILS AS PER DOCUMENT &PL. | 4 | $345.7K | 5.6% |
| 5 | Sennosides Docusate Sodium Tablet 8 6mg 50mg Red OTHER DETAILS AS PER INV PL | 3 | $306.6K | 4.9% |
| 6 | SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50MG (ORANGE) OTHER DETAILS AS PER INV& PL. | 8 | $303.9K | 4.9% |
| 7 | SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50MG (RED) OTHER DETAILS AS PER INV &PL. | 9 | $294.0K | 4.7% |
| 8 | SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50MG (RED) EACH FILM COATED TABLET CONTAINS:SENNOSIDES USP 8.6MG AS PER INVNOS | 9 | $234.2K | 3.8% |
| 9 | SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50MG (RED) OTHER DETAILS AS PER INV &PL.NOS | 9 | $232.9K | 3.8% |
| 10 | SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50MG (RED) EACH FILM COATED TABLET CONTAINS:SENNOSIDES USP 8.6MG AS PER INV | 4 | $206.9K | 3.3% |
Showing top 10 of 104 Docusate formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA handles the highest volume with 68 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's docusate exports to United States are driven primarily by a handful of large-scale manufacturers. TRUECARE BIOMEDIX with 111 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — TRUECARE BIOMEDIX, TRUE CARE BIOMEDIX, ELYSIUM PHARMACEUTICALS LTD — together account for 92% of total trade value on this route. The average shipment value of $30.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as sennosides & docusate sodium tablet 8.6m and sennosides & docusate sodium tablet 8.6mg/50mg (red), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, PL DEVELOPMENTS is the largest importer with 85 shipments worth $4.0M USD — representing 65% of all docusate imports from India on this route. A total of 39 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $6.2M
- Avg. Shipment
- $30.4K
- Suppliers
- 11
- Buyers
- 39
- Transit (Sea)
- ~21 days
- Annual Growth
- +15.6%
Other Docusate Routes
Unlock the Full India to United States Docusate Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 204 shipments on this route.
Frequently Asked Questions — India to United States Docusate Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Docusate to United States?
The leading Indian exporters of Docusate to United States are TRUECARE BIOMEDIX, TRUE CARE BIOMEDIX, ELYSIUM PHARMACEUTICALS LTD. TRUECARE BIOMEDIX holds the largest market share at approximately 69% of total trade value on this route.
Q What is the total value of Docusate exports from India to United States?
India exports Docusate to United States worth approximately $6.2M USD across 204 recorded shipments. The average value per shipment is $30.4K USD.
Q Which ports does India use to ship Docusate to United States?
The most active port of origin is MUNDRA SEA with 68 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to United States for Docusate?
The average transit time for Docusate shipments from India to United States is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Docusate trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.6% with demand growth tracking at 13.6%. The route is ranked #18 among India's top Docusate export destinations globally.
Q How many suppliers are active on the India to United States Docusate route?
There are currently 11 active Indian suppliers exporting Docusate to United States. The market is moderately concentrated with TRUECARE BIOMEDIX accounting for 69% of total shipment value.
Q Who are the main importers of Docusate from India in United States?
The leading importers of Indian Docusate in United States include PL DEVELOPMENTS, GERICARE PHARMACEUTICALS CORP., GERICARE PHARMACEUTICALS CORP, GERICARE PHARMACEUTICALS, STRIVE PHARMACEUTICALS. PL DEVELOPMENTS is the largest buyer with 85 shipments worth $4.0M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Docusate.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 39 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 204 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
204 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists